Cargando…
Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis
OBJECTIVES: The exact underlying mechanism of rituximab treatment in patients with RA is poorly defined and knowledge about the effect of B cell depletion on immune cells in secondary lymphoid organs is lacking. We analysed lymphoid tissue responses to rituximab in RA patients. METHODS: Fourteen RA...
Autores principales: | Ramwadhdoebe, Tamara H, van Baarsen, Lisa G M, Boumans, Maria J H, Bruijnen, Stefan T G, Safy, Mary, Berger, Ferco H, Semmelink, Johanna F, van der Laken, Conny J, Gerlag, Danielle M, Thurlings, Rogier M, Tak, Paul P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532448/ https://www.ncbi.nlm.nih.gov/pubmed/30649469 http://dx.doi.org/10.1093/rheumatology/key428 |
Ejemplares similares
-
Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering
por: Hähnlein, Janine S., et al.
Publicado: (2018) -
Brief Report: Altered Innate Lymphoid Cell Subsets in Human Lymph Node Biopsy Specimens Obtained During the At‐Risk and Earliest Phases of Rheumatoid Arthritis
por: Rodríguez‐Carrio, Javier, et al.
Publicado: (2016) -
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
por: Bruijnen, Stefan, et al.
Publicado: (2016) -
Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at‐risk phase of autoantibody positive rheumatoid arthritis
por: Ramwadhdoebe, Tamara H., et al.
Publicado: (2016) -
Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis
por: Hähnlein, Janine S., et al.
Publicado: (2018)